The Potential Role of Changes in the Glucose and Lipid Metabolic Pathways in Gastrointestinal Cancer Progression: Strategy in Cancer Therapy

被引:2
作者
Ferns, Gordon A. [1 ]
Shahini Shams Abadi, Milad [2 ,3 ]
Raeisi, Ahmad [4 ]
Arjmand, Mohammad-Hassan [3 ,5 ]
机构
[1] Brighton & Sussex Med Sch, Div Med Educ, Brighton, E Sussex, England
[2] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Cellular & Mol Res Ctr, Dept Microbiol & Immunol, Shahrekord, Iran
[3] Shahrekord Univ Med Sci, Canc Res Ctr, Shahrekord, Iran
[4] Shahrekord Univ Med Sci, Hajar Hosp, Clin Res Dev Unit, Shahrekord, Iran
[5] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Med Plants Res Ctr, Shahrekord, Iran
关键词
Gastrointestinal tumors; Glucose metabolism; Lipid metabolism; Cancer metabolism; FATTY-ACID SYNTHASE; ATP CITRATE LYASE; POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; PYRUVATE-KINASE M2; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; COLON-CANCER; DRUG-RESISTANCE; POOR-PROGNOSIS;
D O I
10.1159/000517771
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Changes in cell metabolism are a well-known feature of some cancers, and this may be involved in the etiology of tumor formation and progression, as well as tumor heterogeneity. These changes may affect fatty acid metabolism and glycolysis and are required to provide the increase in energy necessary for the high rate of proliferation of cancer cells. Gastrointestinal cancers remain a difficult-to-treat cancer, particularly as they are usually diagnosed at a late stage of disease and are associated with poor outcomes. Summary: Recently, the changes in the metabolic pathways, including the expression of the rate-limiting enzymes involved, have been considered to be a potential target for therapy for gastrointestinal tumors. Key Message: A combination of routine chemotherapy drugs with metabolic inhibitors may improve the effectiveness of treatment.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 85 条
  • [71] Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway
    Wang, Haiyu
    Xi, Qiulei
    Wu, Guohao
    [J]. CANCER MEDICINE, 2016, 5 (07): : 1599 - 1606
  • [72] Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer
    Wang, Peng
    Mai, Cong
    Wei, Yong-li
    Zhao, Jing-jing
    Hu, Yu-min
    Zeng, Zhao-lei
    Yang, Jing
    Lu, Wen-hua
    Xu, Rui-hua
    Huang, Peng
    [J]. MEDICAL ONCOLOGY, 2013, 30 (02)
  • [73] WARBURG O, 1956, SCIENCE, V124, P269
  • [74] ORIGIN OF CANCER CELLS
    WARBURG, O
    [J]. SCIENCE, 1956, 123 (3191) : 309 - 314
  • [75] TRICARBALLYLATE AND HYDROXYCITRATE - SUBSTRATE AND INHIBITOR OF ATP - CITRATE OXALOACETATE LYASE
    WATSON, JA
    FANG, M
    LOWENSTEIN, JM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1969, 135 (1-2) : 209 - +
  • [76] Crystal structure of the 500-kDa yeast acetyl-CoA carboxylase holoenzyme dimer
    Wei, Jia
    Tong, Liang
    [J]. NATURE, 2015, 526 (7575) : 723 - 727
  • [77] Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies
    Wu, Jiayuan
    Hu, Liren
    Chen, Manyu
    Cao, Wenjun
    Chen, Haicong
    He, Taiping
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 4277 - 4288
  • [78] Dual roles of PKM2 in cancer metabolism
    Wu, Songfang
    Le, Huangying
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2013, 45 (01) : 27 - 35
  • [79] PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
    Yang, Weiwei
    Xia, Yan
    Hawke, David
    Li, Xinjian
    Liang, Ji
    Xing, Dongming
    Aldape, Kenneth
    Hunter, Tony
    Yung, W. K. Alfred
    Lu, Zhimin
    [J]. CELL, 2012, 150 (04) : 685 - 696
  • [80] Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
    Yarla, Nagendra Sastry
    Bishayee, Anupam
    Sethi, Gautam
    Reddanna, Pallu
    Kalle, Arunasree M.
    Dhananjaya, Bhadrapura Lakkappa
    Dowluru, Kaladhar S. V. G. K.
    Chintala, Ramakrishna
    Duddukuri, Govinda Rao
    [J]. SEMINARS IN CANCER BIOLOGY, 2016, 40-41 : 48 - 81